Emergent BioSolutions Inc
LSE:0IGA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Emergent BioSolutions Inc
LSE:0IGA
|
US |
|
C
|
Conrad Asia Energy Ltd
ASX:CRD
|
ID |
|
O
|
Oeneo SA
F:O64
|
FR |
|
T
|
TAG Immobilien AG
XHAN:TEG
|
DE |
|
ITAB Shop Concept AB
F:29I0
|
SE |
|
O
|
OPKO Health Inc
XMUN:XCY
|
US |
|
L
|
L B Foster Co
F:LB1A
|
US |
|
S
|
Solteq Oyj
OMXH:SOLTEQ
|
FI |
|
S
|
Schneider Electric SE
XHAN:SND
|
FR |
|
Samsara Inc
NYSE:IOT
|
US |
|
Emerald Holding Inc
NYSE:EEX
|
US |
|
Focusrite PLC
LSE:TUNE
|
UK |
|
O
|
Oil and Gas Development Co Ltd
KAR:OGDC
|
PK |
|
T
|
Thaifoods Group PCL
SET:TFG
|
TH |
|
Daxor Corp
F:DX5
|
US |
|
S
|
SBM Offshore NV
VSE:SBMO
|
NL |
|
A
|
Aclaris Therapeutics Inc
SWB:8AT
|
US |
|
J
|
Jack in the Box Inc
SWB:JBX
|
US |
|
L
|
Leifheit AG
F:LEI
|
DE |
|
F
|
Fresh Vine Wine Inc
AMEX:VINE
|
US |
|
S
|
Stratasys Ltd
SWB:SCY
|
US |
|
I
|
Invesco Mortgage Capital Inc
F:7M2
|
US |
|
E
|
Engie SA
XHAN:GZF
|
FR |
Wall St Price Targets
0IGA Price Targets Summary
Emergent BioSolutions Inc
According to Wall Street analysts, the average 1-year price target for 0IGA is 12.39 USD with a low forecast of 12.27 USD and a high forecast of 12.76 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IGA's stock price target?
Price Target
12.39
USD
According to Wall Street analysts, the average 1-year price target for 0IGA is 12.39 USD with a low forecast of 12.27 USD and a high forecast of 12.76 USD.
What is the Revenue forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is 4%.
What is the Gross Profit forecast for Emergent BioSolutions Inc?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 1 year is -9%.
What is the Operating Income forecast for Emergent BioSolutions Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 7 years is 17%.
What is the Net Income forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 1 year is 4%.
